Clinical Trial Update: Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated sequential teriparatide followed by raloxifene for postmenopausal osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Raloxifene HCl (raloxifene)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED